AXGT Insider Trading Activity and SEC Form 4 Filings
AXGT insider trading summary
No open-market insider purchases or sales of Axovant Gene Therapies Ltd. (AXGT) have been reported on SEC Form 4 in the past 12 months.
Latest AXGT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 8, 2020 | Pavan Cheruvu | Principal Executive Officer | Buy | $103K (37,500 @ $2.74) |
| Jul 8, 2020 | Atul Pande | Director | Buy | $27K (10,000 @ $2.73) |
| Mar 16, 2020 | Atul Pande | Director | Buy | $18K (10,000 @ $1.78) |
| Feb 24, 2020 | Roivant Sciences Ltd. | 10% Owner | Buy | $20.0M (5,333,333 @ $3.75) |
| Jun 14, 2019 | Atul Pande | Director | Buy | $18K (3,370 @ $5.22) |
| Jun 14, 2019 | Pavan Cheruvu | Chief Executive Officer | Buy | $39K (7,500 @ $5.21) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.